Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and is estimated to affect around 30 per cent of the European population. Chronic fatty liver disease can lead to irreversible cirrhosis of the liver, for which the only treatment is a liver transplant. The early detection of patients with non-alcoholic fatty liver disease is therefore particularly important.
Non-alcoholic fatty liver disease, particularly advanced steatohepatitis (NASH, also known as fatty liver hepatitis), is associated with significant changes in the immune cells within the liver. Only recently has the increased accumulation of a subtype of phagocytes (macrophages), on the surface of which the TREM2 receptor is present in high quantities, been described in fatty liver. Nevertheless, the role of TREM2-positive macrophages in the context of fatty liver disease was previously unknown.
The research team at MedUni Vienna, led by Christoph Binder and Tim Hendrikx from the Clinical Institute of Laboratory Medicine, was able to demonstrate in an animal model that these specific phagocytes play a protective role in fibrosis – a precursor to liver cirrhosis. These cells are found in increased numbers in the affected areas of the liver during inflammatory processes associated with non-alcoholic fatty liver disease, where they accumulate particularly in areas of cell damage and fibrosis.
“By strengthening the protective function of TREM2-positive macrophages, new therapeutic approaches for the treatment of fatty liver hepatitis could be developed,” says Florentina Porsch, co-first author of the study.
TREM2 is present in the body both as a membrane receptor on cells and in a soluble form (sTREM2), which can be detected in the blood. “TREM2 in its soluble form is an excellent biomarker for identifying and monitoring the status of advanced liver disease, which, if left untreated, can progress from fatty liver disease to incurable liver cirrhosis,” explains lead author Tim Hendrikx from the Clinical Institute of Laboratory Medicine at MedUni Vienna.
Reference:
Medical University of Vienna
Hendrikx T et al., Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localise to fibrotic areas and limit NASH, J Hepatol. DOI: 10.1016/j.jhep.2022.06.004
https://www.sciencedirect.com/science/article/pii/S0168827822003592
#non-alcoholicfatty liver #NAFLD #NASH #TREM2 #liver cirrhosis #fibrosis #fatty liver steatohepatitis #medicine